Hepatocellular carcinoma, novel therapies on the horizon

von El Dika, Imane, Makki, Iman, Abou-Alfa, Ghassan K.
Veröffentlicht in Chin Clin Oncol (2020)

Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223

von Mukherji, Deborah, El Dika, Imane, Temraz, Sally, Haidar, Mohammed, Shamseddine, Ali
Veröffentlicht 2014

Sunitinib Induced Thrombotic Thrombocytopenic Purpura in addition to Severe Hypothyroidism: A Case Report and Review of the Literature

von El Dika, Imane, Mukherji, Deborah, Temraz, Sally, Assi, Rita, Shamseddine, Ali
Veröffentlicht 2014

Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature

von Assi, Rita, Hamieh, Lana, Mukherji, Deborah, Haydar, Ali, Temraz, Sally, El-Dika, Imane, Shamseddine, Ali
Veröffentlicht in J Gastrointest Oncol (2015)

Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma

von Greally, Megan, Agarwal, Rajiv, El Dika, Imane, Shamseddine, Ali, El-Olayan, Ashwaq, Haibe, Yolla, Paroder, Viktoriya, Shia, Jinru, Abou-Alfa, Ghassan K., Ku, Geoffrey Y.
Veröffentlicht in J Gastrointest Oncol (2019)

A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma

von Abou‐Alfa, Ghassan K., Miksad, Rebecca A., Tejani, Mohamedtaki A., Williamson, Stephen, Gutierrez, Martin E., Olowokure, Olugbenga O., Sharma, Manish R., El Dika, Imane, Sherman, Matthew L., Pandya, Shuchi S.
Veröffentlicht in Oncologist (2018)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib

von El Dika, Imane, Capanu, Marinela, Chou, Joanne F., Harding, James J., Ly, Michele, Hrabovsky, Anna D., Do, Richard K.G., Shia, Jinru, Millang, Brittanie, Ma, Jennifer, O’Reilly, Eileen M., Abou‐Alfa, Ghassan K.
Veröffentlicht in Cancer Med (2020)

A Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with U...

von El Dika, Imane, Mayer, Robert J., Venook, Alan P., Capanu, Marinela, LaQuaglia, Michael P., Kobos, Rachel, O'Neill, Allison F., Chou, Joanne F., Ly, Michele, Ang, Celina, O'Reilly, Eileen M., Gordan, John D., Abou‐Alfa, Ghassan K.
Veröffentlicht in Oncologist (2020)

An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intraveno...

von El Dika, Imane, Lim, Ho Yeong, Yong, Wei Peng, Lin, Chia‐Chi, Yoon, Jung‐Hwan, Modiano, Manuel, Freilich, Bradley, Choi, Hye Jin, Chao, Tsu‐Yi, Kelley, Robin K., Brown, Joanne, Knox, Jennifer, Ryoo, Baek‐Yeol, Yau, Thomas, Abou‐Alfa, Ghassan K.
Veröffentlicht in Oncologist (2018)

Germline Alterations in Patients with Biliary Tract Cancers: A Spectrum of Significant and Previously Under Appreciated Findings

von Maynard, Hannah, Stadler, Zsofia K., Berger, Michael F., Solit, David B., Ly, Michele, Lowery, Maeve A., Mandelker, Diana, Zhang, Liying, Jordan, Emmett, El Dika, Imane, Kemel, Yelena, Ladanyi, Marc, Robson, Mark E., O’Reilly, Eileen M., Abou-Alfa, Ghassan K.
Veröffentlicht in Cancer (2020)

An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses

von Vasan, Neil, Braghiroli, Maria Ignez, Shoushtari, Alexander N., Do, Richard Kinh Gian, Edelweiss, Marcia, Shamseddine, Ali, Faraj, Walid, Mukherji, Deborah, Haydar, Ali, Olayan, Ashwaq, Sabatin, Fouad, Assi, Rita, El Dika, Imane, Saltz, Leonard B., Abou-Alfa, Ghassan K., O’Reilly, Eileen M.
Veröffentlicht in J Gastrointest Oncol (2017)

Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma

von Harding, James J., Kelley, Robin K., Tan, Benjamin, Capanu, Marinela, Do, Gian Kinh, Shia, Jinru, Chou, Joanne F., Ferrer, Christine S., Boussayoud, Chayma, Muenkel, Kerri, Yarmohammadi, Hooman, El Dika, Imane, Khalil, Danny N., Ruiz, Carmen, Rodriguez‐Lee, Mariam, Kuhn, Peter, Wilton, John, Iyer, Renuka, Abou‐Alfa, Ghassan K.
Veröffentlicht in Oncologist (2020)

Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies

von Vyas, Monika, Firat, Canan, Hechtman, Jaclyn F., Weiser, Martin R., Yaeger, Rona, Vanderbilt, Chad, Benhamida, Jamal K., Keshinro, Ajaratu, Zhang, Liying, Ntiamoah, Peter, Gonzalez, Marco, Andrade, Rebecca, El Dika, Imane, Markowitz, Arnold J., Smith, J. Joshua, Garcia-Aguilar, Julio, Vakiani, Efsevia, Klimstra, David S., Stadler, Zsofia K., Shia, Jinru
Veröffentlicht in Fam Cancer (2020)

Comprehensive molecular profiling of intra- and extrahepatic cholangiocarcinomas: potential targets for intervention.

von Lowery, Maeve A., Ptashkin, Ryan, Jordan, Emmet, Berger, Michael F., Zehir, Ahmet, Capanu, Marinela, Kemeny, Nancy E., O’Reilly, Eileen M., El-Dika, Imane, Jarnagin, William R., Harding, James J., D’Angelica, Michael I., Cercek, Andrea, Hechtman, Jaclyn F., Solit, David B., Schultz, Nikolaus, Hyman, David M., Klimstra, David S., Saltz, Leonard B., Abou-Alfa, Ghassan K.
Veröffentlicht in Clin Cancer Res (2018)

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial

von Abou-Alfa, Ghassan K., Shi, Qian, Knox, Jennifer J., Kaubisch, Andreas, Niedzwiecki, Donna, Posey, James, Tan, Benjamin R., Kavan, Petr, Goel, Rakesh, Lammers, Philip E., Bekaii-Saab, Tanios S., Tam, Vincent C., Rajdev, Lakshmi, Kelley, Robin K., El Dika, Imane, Zemla, Tyler, Potaracke, Ryan I., Balletti, Jennifer, El-Khoueiry, Anthony B., Harding, James J., Suga, Jennifer M., Schwartz, Lawrence H., Goldberg, Richard M., Bertagnolli, Monica M., Meyerhardt, Jeffrey, O’Reilly, Eileen M., Venook, Alan P.
Veröffentlicht in JAMA Oncol (2019)

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

von Park, Wungki, Chen, Jiapeng, Chou, Joanne F., Varghese, Anna, Yu, Kenneth, Wong, Winston, Capanu, Marinela, Balachandran, Vinod, McIntyre, Caitlin A., El Dika, Imane, Khalil, Danny N., Harding, James J., Ghalehsari, Nima, McKinell, Zoe, Chalasani, Sree, Makarov, Vladimir, Selenica, Pier, Pei, Xin, Lecomte, Nicolas, Kelsen, David, Abou-Alfa, Ghassan K., Robson, Mark E., Zhang, Liying, Berger, Michael F., Schultz, Nikolaus, Chan, Timothy A., Powell, Simon, Reis-Filho, Jorge S., Iacobuzio-Donahue, Christine A., Riaz, Nadeem, O’Reilly, Eileen M.
Veröffentlicht in Clin Cancer Res (2020)